Thalidomide: current and potential clinical applications
Top Cited Papers
- 16 August 2004
- journal article
- review article
- Published by Elsevier
- Vol. 108 (6) , 487-495
- https://doi.org/10.1016/s0002-9343(99)00408-8
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Thalidomide as an Anti-TNF-α Inhibitor: Implications for Clinical UseClinical Immunology and Immunopathology, 1996
- Rediscovering thalidomide: A review of its mechanism of action, side effects, and potential usesJournal of the American Academy of Dermatology, 1996
- The treatment of microsporidial diarrhoea with thalidomideAIDS, 1995
- Use of thalidomide in treatment and maintenance of idiopathic esophageal ulcers in HIV+ individualsDigestive Diseases and Sciences, 1995
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Thalidomide for systemic lupus erythematosusThe Lancet, 1992
- Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: Successful treatment with thalidomideJournal of the American Academy of Dermatology, 1990
- Significant response of oral aphthosis to thalidomide treatmentJournal of the American Academy of Dermatology, 1985
- Studies on the anti-inflammatory properties of thalidomide: Effects on polymorphonuclear leukocytes and monocytesJournal of the American Academy of Dermatology, 1984